ADVANCE research 20 years later
Observational and interventional studies have shown that intensive blood pressure control may benefit in patients with diabetes. The Action in Diabetes and Vascular Disease: Preterax and Diarnicron MR Controlled Evaluation (ADVANCE) international randomized, controlled, clinical trial was launched i...
Saved in:
| Main Authors: | Zh. D. Kobalava, E. L. Kolesnik |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2021-09-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/6281 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Algorithm for differential administration of combination antihypertensive therapy in patients with Type 2 diabetes mellitus
by: O. A. Koshelskaya, et al.
Published: (2013-08-01) -
New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences
by: Zh. D. Kobalava, et al.
Published: (2019-03-01) -
Heterogeneous Effects of Intensive Glycemic and Blood Pressure on Cardiovascular Events Among Diabetes by Living Arrangements
by: Kanta Kiyohara, et al.
Published: (2024-07-01) -
Evidence born from ASCOT trial – still important after 15 years
by: O. P. Rotar
Published: (2021-09-01) -
ORIGINAL Programme: study background and design
by: Yu. A. Karpov
Published: (2010-02-01)